Graham Holdings Company Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $4.97B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| GHC | KYMR | |
|---|---|---|
Market Cap | $4.97B | $8.87B |
Volume | 27,383 | 779,107 |
Sector | Industrials | Health |
52-Week High | $1.23K | $127.31 |
52-Week Low | $949.84 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $8.26B |
Dividend Yield | 0.64% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →